| Fiscal Period | 2025 | 2024 | 2023 |
|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 |
| Issuance( Retirement)of Debt Net | 5.05 | 3.10 | 0.95 |
| Net Changein Cash | 4.30 | 0.38 | 0.28 |
| Cash Taxes Paid | 1.11 | 0.34 | 0.12 |
| Net Income/ Starting Line | 4.20 | 1.12 | 0.30 |
| Changesin Working Capital | -6.69 | -3.72 | -0.80 |
| Cashfrom Operating Activities | -1.84 | -2.17 | -0.18 |
| Cashfrom Financing Activities | 6.68 | 2.86 | 0.81 |
| Issuance( Retirement)of Stock Net | 0.70 | 0.00 | 0.00 |
| Depreciation/ Depletion | 0.27 | 0.21 | 0.18 |
| Other Investing Cash Flow Items Total | 0.08 | 0.03 | - |
| Capital Expenditures | -0.62 | -0.33 | -0.35 |
| period Type | - | - | - |
| Non- Cash Items | 0.39 | 0.21 | 0.14 |
| Financing Cash Flow Items | 0.93 | -0.24 | -0.14 |
| period Length | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -0.54 | -0.30 | -0.35 |
Aptus Pharma Dividend Aptus Pharma Bonus Aptus Pharma News Aptus Pharma AGM Aptus Pharma Rights Aptus Pharma Splits Aptus Pharma Board Meetings Aptus Pharma Key Metrics Aptus Pharma Shareholdings Aptus Pharma Profit Loss Aptus Pharma Balance Sheet Aptus Pharma Q1 Results Aptus Pharma Q2 Results Aptus Pharma Q3 Results Aptus Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks